New developments in psychopharmacology of attention deficit hyperactivity disorder

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.10, 2001-10, pp. : 1797-1807

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 590-594

Bentham Science Publishers

Access to resources Recommend Favorite

New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen Suzuki Alejandra R McGough James J

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

New drugs for the treatment of attention-deficit/hyperactivity disorder

By Pataki Caroly S Feinberg David T McGough James J

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 293-302

Informa Healthcare

Access to resources Recommend Favorite

Adult Attention Deficit Hyperactivity Disorder

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 8, 2004-12 ,pp. : 1-7

Guilford Publications Inc

Access to resources Recommend Favorite

Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder

By Steer Christopher

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 691-705

Adis International

Access to resources Recommend Favorite